GSK-A1
GSK-A1 Basic information
- Product Name:
- GSK-A1
- Synonyms:
-
- GSK-A1
- PI4KA inhibitor-A1
- 3-Pyridinesulfonamide, 5-[2-amino-1-[4-(4-morpholinyl)phenyl]-1H-benzimidazol-6-yl]-N-(2-fluorophenyl)-2-methoxy-
- 5-{2-Amino-1-[4-(4-morpholinyl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxy-3-pyridinesulfonamide
- PtdIns(4,5)P2,PI4KIIIα,inhibit,Hepatitis C virus,PI4K,GSK A1,GSK-A1,Phosphatidylinositol 4 kinases,PtdIns(4)P,phosphatidylinositol 4-kinase PI4KA,HCV,Inhibitor,PI4 kinases,GSKA1,GSK-A-1
- CAS:
- 1416334-69-4
- MF:
- C29H27FN6O4S
- MW:
- 574.63
- Mol File:
- 1416334-69-4.mol
GSK-A1 Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- DMSO: 2 mg/ml
- form
- A solid
- color
- White to off-white
GSK-A1 Usage And Synthesis
Uses
GSK-A1 is a selective type III phosphatidylinositol 4-kinase PI4KA (PI4KIIIα) inhibitor with a pIC50 of 8.5-9.8. GSK-A1 inhibits PtdIns(4,5)P2 resynthesis with an IC50 of about 3 nM. GSK-A1 potently decreases the levels of PtdIns(4)P with a negligible effect on PtdIns(4,5)P2. GSK-A1 has?the?potential?for?anti-hepatitis C virus (HCV) research[1].
Biological Activity
GSK-A1 is an inhibitor of phosphatidylinositol 4-kinase IIIα (PI4KIIIα; IC50 = 3.16 nM).1 It is selective for PI4KIIIα over PI4KIIIβ, PI3Kα, PI3Kβ, and PI3Kδ (IC50s = >50 nM) but also inhibits PI3Kγ (IC50 = 15.8 nM). GSK-A1 decreases the levels of phosphatidylinositol 4-phosphate (PtdIns-(4)-P1) but not PtdIns-(4,5)-P2 in HEK293 cells expressing the angiotensin II type 1 (AT1) receptor (IC50 = 3 nM). GSK-A1 inhibits hepatitis C virus (HCV) genotype 1a and 1b replication.
IC 50
PI4KA: 8.5-9.8 (pIC50); PI4KB: 7.2-7.7 (pIC50); PI4K2A: <5 (pIC50); PI4K2B: <5 (pIC50)
References
1.Bojjireddy, N., Botyanszki, J., Hammond, G., et al.Pharmacological and genetic targeting of the PI4KA enzyme reveals its important role in maintaining plasma membrane phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate levelsJ. Biol. Chem.289(9)6120-6132(2014)
GSK-A1Supplier
- Tel
- 021-52996696,15000506266 15000506266
- Tel
- +86-400-851-9921
- sales@pharmacodia.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
- Tel
- 021-QQ:65489617 15618227136
- Sales@ATKchemical.com
GSK-A1(1416334-69-4)Related Product Information
- GSK2837808A
- GSK6853
- S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide
- GSK864
- GSK484
- GSK J4 HCl
- GSK 2334470
- GSK2982772
- GSK2636771
- Benzeneacetamide, α-[[6-(4-amino-1-piperidinyl)-3,5-dicyano-4-ethyl-2-pyridinyl]thio]-
- GSK778
- N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide
- GSK 2033
- 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate
- N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide
- GSK-2256098
- GSK215